G
Gorka Orive
Researcher at University of the Basque Country
Publications - 371
Citations - 18068
Gorka Orive is an academic researcher from University of the Basque Country. The author has contributed to research in topics: Medicine & Platelet-rich plasma. The author has an hindex of 63, co-authored 327 publications receiving 14433 citations. Previous affiliations of Gorka Orive include University of Barcelona & Leonardo.
Papers
More filters
Journal ArticleDOI
Cell encapsulation: promise and progress.
Gorka Orive,Rosa Maria Hernandez,Alicia R. Gascón,Riccardo Calafiore,Thomas Ming Swi Chang,Paul de Vos,Gonzalo Hortelano,David Hunkeler,Igor Lacík,A. M. James Shapiro,José Luis Pedraz +10 more
TL;DR: This commentary discusses the reasons for this, summarizes recent progress in the field and outlines what is needed to bring this technology closer to clinical application.
Journal ArticleDOI
New insights into and novel applications for platelet-rich fibrin therapies
TL;DR: The therapeutic use of autologous platelet-rich plasma is highlighted and some of the obstacles and challenges that need to be addressed to maintain progress in this field are discussed.
Journal ArticleDOI
The potential impact of the preparation rich in growth factors (PRGF) in different medical fields.
TL;DR: The important progress that has been accomplished in the field of platelet-rich preparations in the last few years is discussed and some of the most interesting therapeutic applications of this technology are discussed.
Journal ArticleDOI
Biomaterials for promoting brain protection, repair and regeneration.
TL;DR: Biomaterials are likely to have an increasingly important role in the treatment of nervous system disorders because nanotechnology allows greater control over material–cell interactions that induce specific developmental processes and cellular responses including differentiation, migration and outgrowth.
Journal ArticleDOI
A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis.
Mikel Sánchez,Nicolás Fiz,Juan Azofra,Jaime Usabiaga,Enmanuel Aduriz Recalde,Antonio Garcia Gutierrez,Javier Albillos,Ramón Garate,José Javier Aguirre,Sabino Padilla,Gorka Orive,Eduardo Anitua +11 more
TL;DR: Plasma rich in growth factors showed superior short-term results when compared with HA in a randomized controlled trial, with a comparable safety profile, in alleviating symptoms of mild to moderate osteoarthritis of the knee.